
PromiCell Launches Investment Campaign to Advance Breakthrough Cell Therapy for Cancer
PromiCell, a clinical-stage immunotherapy company, launches an accredited investor-only campaign to advance next-gen CAR T & TCR T cancer treatments. MIAMI, FL, UNITED STATES, March 18, 2025 /EINPresswire.com/ -- PromiCell Launches …